Publication | Closed Access

A peptide-based vaccine ACP derived from antigens of Mycobacterium tuberculosis induced Th1 response but failed to enhance the protective efficacy of BCG in mice

VaccinationVaccine DevelopmentVaccine TargetMycobacterium TuberculosisImmunologyAntigen ProcessingT Cell ImmunityHumoral ImmunityTh1 ResponseVaccine DesignMedicinePeptide-based Vaccine Acp